CD8A and neoplasm: One school of thought is that effector CD8+ T cells producing high amounts of interferon-gamma are most effective at eliminating tumors, while other investigators believe that naïve or early memory CD8+ T cells which differentiate and expand at the tumor site are superior for eliciting long-lasting anti-tumor immunity (60–62).